Scorsetti, M., Comito, T., Clerici, E., Franzese, C., Tozzi, A., Iftode, C., . . . Cozzi, L. (2018). Phase II trial on SBRT for unresectable liver metastases: Long-term outcome and prognostic factors of survival after 5 years of follow-up. Radiat Oncol.
استشهاد بنمط شيكاغوScorsetti, Marta, et al. "Phase II Trial On SBRT for Unresectable Liver Metastases: Long-term Outcome and Prognostic Factors of Survival After 5 years of Follow-up." Radiat Oncol 2018.
MLA استشهادScorsetti, Marta, et al. "Phase II Trial On SBRT for Unresectable Liver Metastases: Long-term Outcome and Prognostic Factors of Survival After 5 years of Follow-up." Radiat Oncol 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.